These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

115 related items for PubMed ID: 7338523

  • 1. Anticoagulant activity of heparin octasaccharide.
    Ototani N, Yosizawa Z.
    J Biochem; 1981 Nov; 90(5):1553-6. PubMed ID: 7338523
    [Abstract] [Full Text] [Related]

  • 2. Structure and biological activity of finback-whale (Balaenoptera physalus L.) heparin octasaccharide. Chemical, carbon-13 nuclear-magnetic-resonance, enzymic and biological studies.
    Ototani N, Kikuchi M, Yosizawa Z.
    Biochem J; 1982 Jul 01; 205(1):23-30. PubMed ID: 7126178
    [Abstract] [Full Text] [Related]

  • 3. Thrombin-inhibitory activity of whale heparin oligosaccharides.
    Ototani N, Kodama C, Kikuchi M, Yosizawa Z.
    J Biochem; 1984 Dec 01; 96(6):1695-703. PubMed ID: 6530392
    [Abstract] [Full Text] [Related]

  • 4. Anticoagulant properties of heparin preparations from different animal sources with equivalent high affinity for antithrombin III.
    Nagasawa K, Uchiyama H.
    J Biochem; 1984 Mar 01; 95(3):619-26. PubMed ID: 6725227
    [Abstract] [Full Text] [Related]

  • 5. Anticoagulant activities of heparin oligosaccharides and their neutralization by platelet factor 4.
    Lane DA, Denton J, Flynn AM, Thunberg L, Lindahl U.
    Biochem J; 1984 Mar 15; 218(3):725-32. PubMed ID: 6721831
    [Abstract] [Full Text] [Related]

  • 6. Extension and structural variability of the antithrombin-binding sequence in heparin.
    Lindahl U, Thunberg L, Bäckström G, Riesenfeld J, Nordling K, Björk I.
    J Biol Chem; 1984 Oct 25; 259(20):12368-76. PubMed ID: 6490618
    [Abstract] [Full Text] [Related]

  • 7. Heparin from bovine intestinal mucosa: glycans with multiple sulfation patterns and anticoagulant effects.
    Tovar AM, Capillé NV, Santos GR, Vairo BC, Oliveira SN, Fonseca RJ, Mourão PA.
    Thromb Haemost; 2012 May 25; 107(5):903-15. PubMed ID: 22437650
    [Abstract] [Full Text] [Related]

  • 8. Activation of heparin cofactor II by heparin oligosaccharides.
    Maimone MM, Tollefsen DM.
    Biochem Biophys Res Commun; 1988 May 16; 152(3):1056-61. PubMed ID: 3377765
    [Abstract] [Full Text] [Related]

  • 9. Enzymatic preparation of heparin oligosaccharides containing antithrombin III binding sites.
    Toida T, Hileman RE, Smith AE, Vlahova PI, Linhardt RJ.
    J Biol Chem; 1996 Dec 13; 271(50):32040-7. PubMed ID: 8943254
    [Abstract] [Full Text] [Related]

  • 10. Separation of heparin into fractions with different anticoagulant activity by hydrophobic interaction chromatography.
    Ogamo A, Uchiyama H, Nagasawa K.
    Biochim Biophys Acta; 1980 Dec 16; 626(2):477-85. PubMed ID: 7213665
    [Abstract] [Full Text] [Related]

  • 11. Separation of heparin on Sepharose CL-4B in the presence of high concentrations of ammonium sulphate.
    Uchiyama H, Fujimoto N, Sakurai K, Nagasawa K.
    J Chromatogr; 1984 Mar 30; 287(1):55-66. PubMed ID: 6725457
    [Abstract] [Full Text] [Related]

  • 12. Multiple functional domains of the heparin molecule.
    Oosta GM, Gardner WT, Beeler DL, Rosenberg RD.
    Proc Natl Acad Sci U S A; 1981 Feb 30; 78(2):829-33. PubMed ID: 6940150
    [Abstract] [Full Text] [Related]

  • 13. Pharmacological activities of heparins obtained from different tissues: enrichment of heparin fractions with high lipoprotein lipase, antihemolytic and anticoagulant activities by molecular sieving and antithrombin III affinity chromatography.
    Bianchini P, Osima B, Parma B, Nader HB, Dietrich CP.
    J Pharmacol Exp Ther; 1982 Feb 30; 220(2):406-10. PubMed ID: 7057400
    [Abstract] [Full Text] [Related]

  • 14. Fucosylated chondroitin sulfate oligosaccharides exert anticoagulant activity by targeting at intrinsic tenase complex with low FXII activation: Importance of sulfation pattern and molecular size.
    Li J, Li S, Yan L, Ding T, Linhardt RJ, Yu Y, Liu X, Liu D, Ye X, Chen S.
    Eur J Med Chem; 2017 Oct 20; 139():191-200. PubMed ID: 28800457
    [Abstract] [Full Text] [Related]

  • 15. Neutralization of heparin-related saccharides by histidine-rich glycoprotein and platelet factor 4.
    Lane DA, Pejler G, Flynn AM, Thompson EA, Lindahl U.
    J Biol Chem; 1986 Mar 25; 261(9):3980-6. PubMed ID: 3949798
    [Abstract] [Full Text] [Related]

  • 16. Isolation and characterization of a heparin with high anticoagulant activity from the clam Tapes phylippinarum: evidence for the presence of a high content of antithrombin III binding site.
    Cesaretti M, Luppi E, Maccari F, Volpi N.
    Glycobiology; 2004 Dec 25; 14(12):1275-84. PubMed ID: 15253929
    [Abstract] [Full Text] [Related]

  • 17. Differential anticoagulant activity of heparin fragments prepared using microbial heparinase.
    Linhardt RJ, Grant A, Cooney CL, Langer R.
    J Biol Chem; 1982 Jul 10; 257(13):7310-3. PubMed ID: 7085627
    [Abstract] [Full Text] [Related]

  • 18. Comparative studies on the structures of highly active and relatively inactive forms of whale heparin.
    Ototani N, Kikuchi M, Yosizawa Z.
    J Biochem; 1981 Jul 10; 90(1):241-6. PubMed ID: 7287679
    [Abstract] [Full Text] [Related]

  • 19. Anticoagulant synergism of heparin and activated protein C in vitro. Role of a novel anticoagulant mechanism of heparin, enhancement of inactivation of factor V by activated protein C.
    Petäjä J, Fernández JA, Gruber A, Griffin JH.
    J Clin Invest; 1997 Jun 01; 99(11):2655-63. PubMed ID: 9169495
    [Abstract] [Full Text] [Related]

  • 20. Biological implications of the structural, antithrombin affinity and anticoagulant activity relationships among vertebrate heparins and heparan sulphates.
    Hovingh P, Piepkorn M, Linker A.
    Biochem J; 1986 Jul 15; 237(2):573-81. PubMed ID: 2948492
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.